Toku Taku Toys

Published in AJMRR Clinical Study, this clinical trial introduces Presigen IV as a pioneering biocellular therapy. With a patient-centered trial design and promising efficacy data, the study sets a new precedent in the AJMRR Clinical Study landscape for innovation in ocular treatment and vision preservation.